| Pharmaceutical active ingredients: |
| Gemcitabine Hydrochloride |
| Available forms, composition and doses of Gemzitabin: |
| Injectable; Injection; Gemcitabine Hydrochloride 1 gInjectable; Injection; Gemcitabine Hydrochloride 200 mg |
| Gemzitabin medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01BC05 - Gemcitabine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Teva |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Gemcitera | Gemcitabine Hydrochloride | Tuteur Laboratorio; IMA Laboratorio |
| Gemcitover | Gemcitabine Hydrochloride | Lans-Pharm |
| Gemtabine | Gemcitabine Hydrochloride | Korea United Pharmaceutical; Qualimed Pharma |
| Gemtro | Gemcitabine Hydrochloride | Eli Lilly |
| Gemzar | Gemcitabine Hydrochloride | Eli Lilly; Diethelm; DKSH; Four Star; Y.C. Woo; Zuellig Pharma |
| Gezt | Gemcitabine Hydrochloride | Richmond Laboratorios |
| Gitrabin | Gemcitabine Hydrochloride | Actavis; Apex Pharma Marketing; Firma Chun Cheong; Zuellig Pharma |
| Lifogem | Gemcitabine Hydrochloride | Samarth Pharma |
| Oncogem | Gemcitabine Hydrochloride | Cipla |
| Oncoril | Gemcitabine Hydrochloride | Naprod Life Sciences; Ambica International Trading Corporation |